Innate Pharma SA IPHA

Henry Wheeler — Interim Chief Executive Officer

Herve Brailly — Chairman of the Board

Sonia Quaratino — Chief Medical Officer

Yannis Morel — Executive Vice President, Product Portfolio Strategy and Business Development

Frederic Lombard — Chief Financial Officer

−3.4%1d on move date−4.2% vs SPY3d−8.1%5d−4.7%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IPHA calls or request research access.

More IPHA calls Browse calls Request research access